$Comparative analysis of serum galanin levels in patients with coronary artery disease with and without heart failure with reduced ejection fraction and in individuals without cardiovascular diseases$

Comparative analysis of serum galanin levels in patients with coronary artery disease with and without heart failure with reduced ejection fraction and in individuals without cardiovascular diseases

Aim. To study the level of the neuro-regulatory peptide galanin in patients with coronary artery disease (CAD) with and without heart failure with reduced ejection fraction (HFrEF) in comparison with individuals without cardiovascular disease (CVD) included in the control group.Material and method...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu. S. Timofeev, A. A. Yafarova, A. F. Sheptulina, A. R. Kiselev, V. A. Metelskaya, N. I. Dubovskaya, O. M. Drapkina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2024-11-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	coronary artery disease heart failure galanin
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/4156
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multifaceted role of galanin in brain excitability
by: Nicolas N Rieser, et al.
Published: (2025-07-01)

Modern ideas about the role of the galaninergic system in the pathogenesis of heart failure and myocardial remodeling
by: A. A. Yafarova, et al.
Published: (2023-06-01)

Serum levels of galanin-like peptide and alarin are highly correlated with polycystic ovary syndrome
by: Mengchen Liu, et al.
Published: (2025-03-01)

Potential role of galanine in the treatment of type 2 diabetes mellitus
by: Igor Vladimirovich Dobrokhotov, et al.
Published: (2020-12-01)

Predictive value of serum sortilin, HMGB1, and galanin-like peptide for gestational diabetes mellitus in women with polycystic ovary syndrome
by: Hui Li, et al.
Published: (2025-05-01)

Serum Irisin, Myostatin, and Myonectin Correlate with Metabolic Health Markers, Liver Disease Progression, and Blood Pressure in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease and Hypertension
by: Anna F. Sheptulina, et al.
Published: (2024-10-01)

Interaction of serum heat shock proteins’ levels with the severity of venous congestion in patients with acute decompensated heart failure with preserved ejection fraction
by: Yu. S. Timofeev, et al.
Published: (2024-07-01)

Role of epicardial adipose tissue in the pathogenesis of chronic inflammation in heart failure with preserved ejection fraction
by: O. N. Dzhioeva, et al.
Published: (2024-04-01)

Gut microbiota at different stages of cardiovascular disease continuum
by: A. A. Yafarova, et al.
Published: (2023-12-01)

NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: SCIENTIFIC PROBLEM STATE
by: O. M. Drapkina, et al.
Published: (2017-11-01)

Temporal left ventricular ejection fraction variations and outcomes in wide population of cardiovascular patients with and without heart failure
by: Radosław Szczerba, et al.
Published: (2025-03-01)

Serum megalin levels in type-2 diabetes mellitus with and without cardiovascular disease
by: Sujatha Rajaragupathy, et al.
Published: (2024-11-01)

Heat shock proteins in the assessment of the course and prognosis of heart failure with preserved ejection fraction
by: Yu. S. Timofeev, et al.
Published: (2025-05-01)

Markers of heart failure with preserved ejection fraction in patients with unexplained dyspnea
by: A. A. Ivanova, et al.
Published: (2023-11-01)

Isoaspartate-containing galanin in rat hypothalamus
by: Samuel Okyem, et al.
Published: (2025-03-01)

Plasma branched-chain amino acid concentrations in individuals without cardiovascular diseases versus patients diagnosed with hypertension and coronary artery disease
by: M. V. Kozhevnikova, et al.
Published: (2023-07-01)

Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis.
by: Samuel A Curran, et al.
Published: (2014-01-01)

Combined Serum Albumin and Left Ventricular Ejection Fraction Predict All-Cause Death in Patients with Stable Coronary Artery Disease
by: Hua Zhang, et al.
Published: (2024-01-01)

Significance of catestatin in the pathogenesis of heart failure with preserved ejection fraction in patients with non-obstructive coronary artery disease
by: E. V. Grakova, et al.
Published: (2023-11-01)

Prognostic impact of new‐onset atrial fibrillation in myocardial infarction with and without improved ejection fraction
by: Jiachen Luo, et al.
Published: (2024-12-01)

Serum Osteopontin and Procollagen Type 1 N-Terminal Propeptide Concentrations: Links to Liver Function, Muscle Mass, and Bone Mineral Density in MASLD and Hypertension
by: Anna F. Sheptulina, et al.
Published: (2025-07-01)

Associations of cartilage intermediate layer protein 1 and hypoxia-inducible factor-1-alpha with transthoracic echocardiography results in patients with heart failure with preserved ejection fraction
by: Yu. S. Timofeev, et al.
Published: (2024-06-01)

Hypertension and reduced bone mineral density: unexpected pathogenetic mechanisms
by: A. F. Sheptulina, et al.
Published: (2024-06-01)

THE ROLE OF DIET AND PHYSICAL ACTIVITY IN THERAPY OF CARDIOVASCULAR PATIENTS WITH NORMAL EJECTION FRACTION
by: O. M. Drapkina, et al.
Published: (2017-04-01)

Subclinical Cardiovascular Disease in US Adults With and Without Diabetes
by: Michael Fang, et al.
Published: (2023-06-01)

Increased galanin-galanin receptor 1 signaling, inflammation, and insulin resistance are associated with affective symptoms and chronic fatigue syndrome due to long COVID.
by: Wasim Talib Mahdi Al Masoodi, et al.
Published: (2025-01-01)

Pharmacogenetics in treatment of anthracycline-induced cardiotoxicity in women without prior cardiovascular diseases
by: E. V. Grakova, et al.
Published: (2023-01-01)

PREVENTION OF WOUND COMPLICATIONS IN PATIENTS WITH CORONARY ARTERY DISEASE WITH LOW EJECTION FRACTION OF THE HEART
by: V. V. Plechev, et al.
Published: (2017-01-01)

Role of humoral markers in the pathogenesis of heart failure with preserved ejection fraction in patients with non-obstructive coronary artery disease
by: E. V. Grakova, et al.
Published: (2022-11-01)

Serum Zinc-α2-Glycoprotein Levels in Patients with or without Coronary Artery Disease in Chinese North Population
by: Meijuan Liu, et al.
Published: (2020-01-01)

Association of cardiovascular and fracture risks in women without clinical manifestations of atherosclerosis
by: I. A. Skripnikova, et al.
Published: (2020-12-01)

Revascularization of myocardial infarction without ST segment elevation in multivessel coronary artery disease
by: Sh. J. Khalilov, et al.
Published: (2024-10-01)

The relationship between gut microbiota, chronic systemic inflammation, and endotoxemia in patients with heart failure with preserved ejection fraction
by: A. N. Kaburova, et al.
Published: (2022-10-01)

Assessment of Cardiorespiratory Fitness without Exercise in Elderly Men with Chronic Cardiovascular and Metabolic Diseases
by: Geraldo A. Maranhão Neto, et al.
Published: (2012-01-01)

Prognostic value of serum glycated albumin in acute coronary syndrome patients without standard modifiable cardiovascular risk factors
by: Xiaoming Zhang, et al.
Published: (2024-11-01)

Coronary Artery Disease Doubles Excess Mortality in Patients With Heart Failure With Reduced Ejection Fraction
by: Nanna Anker, et al.
Published: (2025-05-01)

Coronary flow reserve in patients with heart failure with preserved ejection fraction
by: A. V. Mochula, et al.
Published: (2022-03-01)

Changes of the quality of life and efficiency criteria of coronary artery bypass grafting in patients with stable coronary artery disease and preserved left ventricular ejection fraction
by: Yu.A. Borkhalenko, et al.
Published: (2018-06-01)

SGLT2 inhibitor with and without ALDosterone AntagonIst for heart failure with preserved ejection fraction: Design paper
by: João Pedro Ferreira, et al.
Published: (2025-08-01)

Novel Adiposity Indices Are Associated With Poor Prognosis in Heart Failure With Preserved Ejection Fraction Without the Obesity Paradox
by: Shuai Zhang, et al.
Published: (2024-11-01)